A randomized, investigator-sponsored trial comparing active surveillance (AS) to SM-88 maintenance therapy in patients with prostate cancer

Status: Planning

Phase of Trial: Phase II

Latest Information Update: 26 Aug 2020

Price :

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

21 Aug 2020 According to a Tyme Technologies media release, information about this trial will be presented at 2020 Cross-Border Healthcare Webinar Series.
01 Feb 2018 New trial record
30 Jan 2018 According to a Tyme Technologies media release, Mack Roach III, M.D., Professor of Radiation Oncology, Medical Oncology and Urology at the University of California, San Francisco (UCSF), will lead this trial. This trial will be conducted at UCSF and potentially expand to other academic sites.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com